Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Werewolf Therapeutics Inc (NASDAQ: HOWL) closed at $1.02 down -10.53% from its previous closing price of $1.14. In other words, the price has decreased by -$10.53 from its previous closing price. On the day, 4.22 million shares were traded. HOWL stock price reached its highest trading level at $1.13 during the session, while it also had its lowest trading level at $1.02.
Ratios:
For a deeper understanding of Werewolf Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.09 and its Current Ratio is at 8.09. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.62.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on April 03, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $12.
On August 24, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $9.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 12 ’25 when RA CAPITAL MANAGEMENT, L.P. bought 320,913 shares for $0.86 per share. The transaction valued at 275,985 led to the insider holds 6,021,969 shares of the business.
RA CAPITAL MANAGEMENT, L.P. bought 162,539 shares of HOWL for $159,288 on May 14 ’25. The Director now owns 6,237,482 shares after completing the transaction at $0.98 per share. On May 13 ’25, another insider, RA CAPITAL MANAGEMENT, L.P., who serves as the Director of the company, bought 52,974 shares for $0.98 each. As a result, the insider paid 51,915 and bolstered with 6,074,943 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOWL now has a Market Capitalization of 45771072 and an Enterprise Value of -9256881. For the stock, the TTM Price-to-Sale (P/S) ratio is 40.15 while its Price-to-Book (P/B) ratio in mrq is 0.80. Its current Enterprise Value per Revenue stands at -8.099 whereas that against EBITDA is 0.127.
Stock Price History:
The Beta on a monthly basis for HOWL is 0.65, which has changed by -0.5659574 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, HOWL has reached a high of $4.18, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -6.37%, while the 200-Day Moving Average is calculated to be -32.98%.
Shares Statistics:
For the past three months, HOWL has traded an average of 440.27K shares per day and 718040 over the past ten days. A total of 44.83M shares are outstanding, with a floating share count of 33.12M. Insiders hold about 26.20% of the company’s shares, while institutions hold 47.56% stake in the company. Shares short for HOWL as of 1749772800 were 1835810 with a Short Ratio of 4.17, compared to 1747267200 on 2223949. Therefore, it implies a Short% of Shares Outstanding of 1835810 and a Short% of Float of 5.79.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
